The BackPage
Vaccine News Alert

March/April 2022

2022 Immunization Schedules

The 2022 Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules are now available. Child and adolescent updates include:
Dengue - Dengue vaccine has been added to the child and adolescent schedule - A new row has been added with the boxes for children and adolescents aged 9–16 years highlighted in yellow to indicate the recommended age for routine dengue vaccination. The overlying text “Seropositive in endemic areas only (see notes)” has been added to the yellow boxes.
MenACWY - The MenACWY note was updated to include language stating MenACWY vaccines may be administered simultaneously with MenB vaccines if indicated, but at a different anatomic site, when feasible.
Vaccine-specific changes in the 2022 child and adolescent immunization schedule for children and adolescents aged ≤18 years also include new or updated ACIP recommendations for influenza vaccine, and COVID-19 vaccine. More details can be found here:

Signatures for the VFC/VFA Agreements

Each year enrolled providers submit an updated provider agreement. Updated agreements must be complete including the signature of the medical director or equivalent. This must be a physician unless a nurse practitioner (NP) signing the form has an autonomous medical license. Vaccine orders cannot be filled if a provider agreement becomes overdue. Submitting an incomplete agreement may delay vaccine order requests.

Transporting Vaccine

A currently calibrated data logger must always be used to monitor vaccines during transport. Use a hard sided or Styrofoam cooler (Use in conjunction with the Packing Vaccines for Transport during Emergencies tool) with conditioned water bottles and insulating materials to reach the optimal temperature for refrigerated vaccines. Check temperatures often during transport and address temperature excursions before administering the affected vaccines. For most information, see the CDC's toolkit or reach out to your regional consultant for assistance.
VDH_logo-300x59 updates

Updated documents and links include:
“You Must Provide Patients with Vaccine Information Statements (VISs) – It’s Federal Law!" and "Dates of
Current Vaccine Information Statements (VISs)" to reflect new VIS version.

Information about the federal law:
VIS job aid:

Gold Star Awards


Jan 1 to Feb 28, 2022

Outstanding VVFC Compliance
American Kids Care, Annandale
Bayside Pediatrics, Virginia Beach
Bristow Pediatrics, Bristow
Inova Cares, Sterling
Neighborhood Health, Alexandria
Practice of Dr. Bennett, Richmond
Practice of Dr. Nasser, Falls Church

Adult Vaccine Update

ACIP Adult Schedule

Vaccine-specific changes in the 2022 immunization schedule for adults aged ≥19 years include new or updated ACIP recommendations for hepatitis B vaccine, influenza vaccine, pneumococcal vaccines, recombinant zoster vaccine, and COVID-19 vaccine. Changes have also been made to the human papillomavirus; measles, mumps, and rubella; meningococcal; and varicella vaccination sections to improve clarity in the language. More details can be found here:
Pneumococcal - PCV15 (Vaxneuvance) and PCV20 (Prevnar 20) have been added to the table of vaccine abbreviations and trade names. PCV13 (Prevnar 13) has been removed from the list of vaccine abbreviations and trade names.
Hepatitis B - For adults aged 19–59 years, the row is yellow, indicating that HepB vaccination is universally recommended for adults in this age group, and purple for adults aged ≥60 years, indicating that HepB vaccination is recommended for adults in this age group if they have an additional risk factor or another indication.
Recombinant Zoster - The immunocompromising conditions bullet was revised to reflect the new ACIP recommendations for zoster vaccination. This bullet now states “RZV is recommended for use in persons aged 19 years and older who are (or will be) immunodeficient or immunosuppressed because of disease or therapy.”
Are you receiving the BackPage newsletter? If not, please subscribe by visiting either of these pages:
Sign up using the form on the right side of the page.
Email Marketing Powered by MailPoet